These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 19486510

  • 21. Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.
    Lind L, Ingelsson E, Kumar J, Syvänen AC, Axelsson T, Teerlink T.
    Vasc Med; 2013 Aug; 18(4):192-9. PubMed ID: 23892448
    [Abstract] [Full Text] [Related]

  • 22. Relations among glycemic control, circulating endothelial cells, nitric oxide, and flow mediated dilation in patients with type 2 diabetes mellitus.
    Kotb NA, Gaber R, Salah W, Elhendy A.
    Exp Clin Endocrinol Diabetes; 2012 Sep; 120(8):460-5. PubMed ID: 22639396
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of eNOS phosphorylation mediates endothelial dysfunction in renal failure: new effect of asymmetric dimethylarginine.
    Kajimoto H, Kai H, Aoki H, Yasuoka S, Anegawa T, Aoki Y, Ueda S, Okuda S, Imaizumi T.
    Kidney Int; 2012 Apr; 81(8):762-8. PubMed ID: 22297680
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients.
    Pasini AF, Garbin U, Stranieri C, Boccioletti V, Mozzini C, Manfro S, Pasini A, Cominacini M, Cominacini L.
    Am J Hypertens; 2008 Nov; 21(11):1251-7. PubMed ID: 18772860
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Intensive treatment of risk factors in patients with type-2 diabetes mellitus is associated with improvement of endothelial function coupled with a reduction in the levels of plasma asymmetric dimethylarginine and endogenous inhibitor of nitric oxide synthase.
    Yasuda S, Miyazaki S, Kanda M, Goto Y, Suzuki M, Harano Y, Nonogi H.
    Eur Heart J; 2006 May; 27(10):1159-65. PubMed ID: 16627554
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Lack of association between asymmetric dimethylarginine and in vivo microvascular and macrovascular endothelial function in patients with rheumatoid arthritis.
    Sandoo A, Dimitroulas T, Veldhuijzen van Zanten JJ, Smith JP, Metsios GS, Nightingale P, Stavropoulos-Kalinoglou A, Kitas GD.
    Clin Exp Rheumatol; 2012 May; 30(3):388-96. PubMed ID: 22410121
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Decline of popliteal artery flow-mediated dilation with aging and possible involvement of asymmetric dimethylarginine in healthy men.
    Nakamura A, Kajitani S, Sato K, Kanazawa M, Kondo M, Endo H, Nozaki E.
    J Med Ultrason (2001); 2019 Oct; 46(4):503-511. PubMed ID: 31011935
    [Abstract] [Full Text] [Related]

  • 34. Relationship between S-adenosylmethionine, S-adenosylhomocysteine, asymmetric dimethylarginine, and endothelial function in healthy human subjects during experimental hyper- and hypohomocysteinemia.
    Doshi S, McDowell I, Goodfellow J, Stabler S, Boger R, Allen R, Newcombe R, Lewis M, Moat S.
    Metabolism; 2005 Mar; 54(3):351-60. PubMed ID: 15736113
    [Abstract] [Full Text] [Related]

  • 35. Asymmetric dimethylarginine (ADMA) and soluble vascular cell adhesion molecule 1(sVCAM-1) as circulating markers for endothelial dysfunction in patients with pheochromocytoma.
    Vasilev V, Matrozova J, Elenkova A, Vandeva S, Kirilov G, Zacharieva S.
    Exp Clin Endocrinol Diabetes; 2013 Oct; 121(9):551-5. PubMed ID: 24002898
    [Abstract] [Full Text] [Related]

  • 36. Serum asymmetric dimethylarginine and arginine levels predict microvascular and macrovascular complications in type 2 diabetes mellitus.
    Ganz T, Wainstein J, Gilad S, Limor R, Boaz M, Stern N.
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27393712
    [Abstract] [Full Text] [Related]

  • 37. [Urinary albumin excretion and noninvasive assessment of peripheral endothelial dysfunction with high-resolution ultrasound in type 2 diabetic subjects and nondiabetic controls].
    Balletshofer BM, Braun B, Rittig K, Stock J, Riexinger A, Lehn-Stefan A, Häring HU.
    Med Klin (Munich); 2003 Apr 25; 98(5):253-8. PubMed ID: 12721669
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine.
    Stühlinger MC, Oka RK, Graf EE, Schmölzer I, Upson BM, Kapoor O, Szuba A, Malinow MR, Wascher TC, Pachinger O, Cooke JP.
    Circulation; 2003 Aug 26; 108(8):933-8. PubMed ID: 12912818
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.